BiotechTube

zolbetuximab + oxaliplatin + leucovorin + fluorouracil + Pembrolizumab + folinic acid + nivolumab + Docetaxel

Phase 2Active
0 views this week 0 watching💤 Quiet
Interest: 39/100
39
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pharmacokinetics of Zolbetuximab

Conditions

Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer, Pharmacokinetics of Oxaliplatin, Pharmacokinetics of Fluorouracil Bolus (5-FU)

Trial Timeline

Jun 29, 2018 → May 31, 2027

NCT ID
NCT03505320

About zolbetuximab + oxaliplatin + leucovorin + fluorouracil + Pembrolizumab + folinic acid + nivolumab + Docetaxel

zolbetuximab + oxaliplatin + leucovorin + fluorouracil + Pembrolizumab + folinic acid + nivolumab + Docetaxel is a phase 2 stage product being developed by Astellas Pharma for Pharmacokinetics of Zolbetuximab. The current trial status is active. This product is registered under clinical trial identifier NCT03505320. Target conditions include Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer.

What happened to similar drugs?

5 of 5 similar drugs in Pharmacokinetics of Zolbetuximab were approved

Approved (5) Terminated (0) Active (0)
✅tolterodine + mirabegronAstellas PharmaApproved
✅mirabegronAstellas PharmaApproved
✅Prograf + Tacrolimus HexalNovartisApproved
✅Aripiprazole + Aripiprazole + desvenlafaxine succinate sustained releasePfizerApproved
✅Tamoxifen + Tamoxifen and Desvenlafaxine Succinate Sustained ReleasePfizerApproved

Hype Score Breakdown

Clinical
12
Activity
12
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT03505320Phase 2Active

Competing Products

20 competing products in Pharmacokinetics of Zolbetuximab

See all competitors
ProductCompanyStageHype Score
DFD-29 (Minocycline) Fasting + DFD-29 (Minocycline) Fed + Solodyn (Minocycline) FastingDr. Reddy's LaboratoriesPhase 1
26
DRL_PG + Pegfilgrastim Form A + Pegfilgrastim Form BDr. Reddy's LaboratoriesPhase 1
22
GP30341 capsules 200 mg + Standard therapyGEROPHARMPre-clinical
16
GP40221 + ozempicGEROPHARMPhase 1
19
Memantinol tablets, 20 mg + Akatinol Memantine® tablets, 20 mgGEROPHARMPhase 1
19
Rinsulin NPH + Humulin NPHGEROPHARMPre-clinical
16
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
29
DS-8500a + ItraconazoleDaiichi SankyoPhase 1
29
Milademetan + Itraconazole + PosaconazoleDaiichi SankyoPhase 1
29
Pexidartinib + ProbenecidDaiichi SankyoPhase 1
29
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
29
DS-8500aDaiichi SankyoPhase 1
29
Milademetan Treatment A + Milademetan Treatment B + Milademetan Treatment CDaiichi SankyoPhase 1
29
tolterodine + mirabegronAstellas PharmaApproved
43
ASP3652Astellas PharmaPhase 1
29
ASP015K ER + ASP015K IRAstellas PharmaPhase 1
29
YM178 modified release (OCAS) + YM178 immediate release (IR)Astellas PharmaPhase 1
29
Isavuconazole + dextromethorphanAstellas PharmaPhase 1
29
mirabegron + metoprololAstellas PharmaPhase 1
29
ASP015KAstellas PharmaPhase 1
29